Active-ingredient Dossier
Entecavir
Active-ingredient Dossier for Entecavir (nucleoside reverse transcriptase inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled…
- Brand: ENTECAVIR SANDOZ
- Brand: ENTECAVIR VIATRIS
- Brand: ENTECAVIR
- Brand: ENTECAVIR
- Brand: ENTECAVIR-WGR
- Brand: ENTECABARA
- Therapeutic area: Infectious Disease
- Therapeutic area: Hepatology
What is
Entecavir Entecavir is a nucleoside reverse transcriptase inhibitor.
Australian brands containing
Entecavir — ENTECAVIR SANDOZ — ENTECAVIR VIATRIS — ENTECAVIR — ENTECAVIR — ENTECAVIR-WGR
Therapeutic areas
Entecavir is registered in Infectious Disease, with 5 brands containing the ingredient.
Sponsor landscape
Entecavir is marketed by five sponsors: Sun Pharma, Arrotex Pharmaceuticals, Sandoz, Alphapharm, and GM Pharma.
PBS and regulatory activity
One brand containing entecavir has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is 1 July 2006, and one brand has a PBAC outcome recorded.